πŸ‡ΊπŸ‡Έ FDA
Patent

US 9364540

Inhalable medicament

granted A61KA61K31/46A61K47/02

Quick answer

US patent 9364540 (Inhalable medicament) held by Teva Branded Pharmaceutical Products R&D, Inc. expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Teva Branded Pharmaceutical Products R&D, Inc.
Grant date
Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/46, A61K47/02, A61K47/06, A61K47/10